RETRACTED: Application of biosensors in cancers, an overview

• Published in: Frontiers in bioengineering and biotechnology Vol. 11
• Main Author: Quazi, Sameer
• Format: Journal Article
• Language: English
• Published: Frontiers Media S.A 24-08-2023
• Subjects: biomarkers; biosensors; DNA; proteins; RNA; tissue
• ISSN: 2296-4185; 2296-4185
• DOI: 10.3389/fbioe.2023.1193493

The deadliest disease in the world, cancer, kills many people every year. The early detection is the only hope for the survival of malignant cancer patients. As a result, in the preliminary stages of, the diagnosis of cancer biomarkers at the cellular level is critical for improving cancer patient survival rates. For decades, scientists have focused their efforts on the invention of biosensors. Biosensors, in addition to being employed in other practical scenarios, can essentially function as cost effective and highly efficient devices for this purpose. Traditional cancer screening procedures are expensive, time-consuming, and inconvenient for repeat screenings. Biomarker-based cancer diagnosis, on the other hand, is rising as one of the most potential tools for early detection, disease progression monitoring, and eventual cancer treatment. As Biosensor is an analytical device, it allows the selected analyte to bind to the biomolecules being studied (for example RNA, DNA, tissue, proteins, and cells). They can be divided based on the kind of biorecognition or transducer elements on the sensor. Most biosensor analyses necessitate the analyte being labeled with a specific marker. In this review article, the application of distinct variants of biosensors against cancer has been described.